Company
We are a pioneering company focused on cell engineering and genetic circuit technology, powered by cutting-edge artificial intelligence. Our primary goal is to revolutionise the fields of drug discovery and bioproduction by our advanced AI bioinformatics and genetic circuit platform. By harnessing the potential of AI, we aim to accelerate the development of innovative medicines while simultaneously reducing costs and improving the likelihood of success.
Description
Based on our self-developed "AI+Bioinformatics" platform, we explore pain point mechanisms, identification of multiple targets, AI gene circuit design, and the development of stable cell lines and organoids. Our core business model revolves around "Target Identification and AI Gene Circuit Design Discovery + License Out." Within the next two years, we aim to implement multiple pipeline projects, such as our drug discovery platform using intelligent cardiac organoids, through partnerships with advanced global biotechnology companies.
